New predictors of the metabolic syndrome in children--role of adipocytokines (Q36787910)

16 August 2017

1 reference

title

New predictors of the metabolic syndrome in children--role of adipocytokines (English)

1 reference

16 August 2017

1 reference

Antje Körner

1

0 references

Jürgen Kratzsch

series ordinal

2

object named as

Jürgen Kratzsch

1 reference

16 August 2017

6

Wieland Kiess

1 reference

16 August 2017

3

Ruth Gausche

1 reference

16 August 2017

5

Sandra Erbs

1 reference

16 August 2017

4

Michael Schaab

1 reference

PubMed ID

17426657

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

61

1 reference

16 August 2017

6

1 reference

16 August 2017

640-645

1 reference

https://scigraph.springernature.com/pub.10.1203/01.pdr.0000262638.48304.ef

16 August 2017

0 references

cites work

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Clinical aspects of obesity in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Obesity--a critical issue in preventive cardiology: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Computer-guided, population-based screening system for growth disorders (CrescNet) and on-line generation of normative data for growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Auxological computer based network for early detection of disorders of growth and weight attainment

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Nonalcoholic fatty liver disease in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Secretory factors from human adipose tissue and their functional role

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Inverse changes in the serum levels of the soluble leptin receptor and leptin in neonates: relations to anthropometric data

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin before and after weight loss in obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Regulation of adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin: action, regulation and association to insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Endothelial inflammation in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Predictors of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Elevation of serum C-reactive protein levels is associated with obesity in boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adipocytokines, body composition, and fitness in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Gender differences in TNF-alpha levels among obese vs nonobese Latino children

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Long-term metabolic consequences of being born small for gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin expression in human fetal tissues during mid- and late gestation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Serum adiponectin concentrations in newborn infants in early postnatal life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Quantitative genetic analysis of the metabolic syndrome in Hispanic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Circulating Soluble Leptin Receptor and Free Leptin Index during Childhood, Puberty, and Adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

Abundance of adiponectin in the newborn*

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000262638.48304.EF

10.1203/01.PDR.0000262638.48304.EF

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

17426657

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17426657